Lobbying client
CHARLEY'S FUND
Directing donated funding to support research in Duchenne Muscular Dystrophy
Filings
17
Filed by
1
Reported in-house
—
Reported by firms
$160,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2014 to 2017
Filings
17 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
3rd Quarter - Termination (No Activity) 3rd Quarter 2017
|
WINNING STRATEGIES WASHINGTON | — reported |
|
2nd Quarter - Report (No Activity) 2nd Quarter 2017
|
WINNING STRATEGIES WASHINGTON | — reported |
|
1st Quarter - Report 1st Quarter 2017
|
WINNING STRATEGIES WASHINGTON | $10,000 reported |
|
4th Quarter - Report 4th Quarter 2016
|
WINNING STRATEGIES WASHINGTON | $10,000 reported |
|
3rd Quarter - Report 3rd Quarter 2016
|
WINNING STRATEGIES WASHINGTON | $10,000 reported |
|
2nd Quarter - Report 2nd Quarter 2016
|
WINNING STRATEGIES WASHINGTON | $10,000 reported |
|
1st Quarter - Report 1st Quarter 2016
|
WINNING STRATEGIES WASHINGTON | $10,000 reported |
|
4th Quarter - Amendment 4th Quarter 2015
|
WINNING STRATEGIES WASHINGTON | $10,000 reported |
|
4th Quarter - Reportreplaced 4th Quarter 2015
|
WINNING STRATEGIES WASHINGTON | $10,000 reported |
|
3rd Quarter - Report 3rd Quarter 2015
|
WINNING STRATEGIES WASHINGTON | $10,000 reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| WINNING STRATEGIES WASHINGTON | 15 | $160,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 14 |
| Medical/Disease Research/Clinical Labs | MED | 13 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.